POCKiT full of potential miracles for stroke victims
An innovative Cambridge ‘sneak out’ is heading to Buckingham Palace to present its vision of a revolution in treatment for strokes.
POCKiT Diagnostics, which is being nurtured by Cambridge University’s Judge Business School, has won through to the finals of [email protected], founded by the Duke of York.
The business venture is one of 42 young companies who will have just 30 seconds to present a case for support in front of HRH and an audience of leading international business figures at the Palace on November 8.
POCKiT diagnostics is developing a device which swiftly and accurately diagnoses what kind of stroke a patient has suffered, so that effective treatment can be administered.
Currently, 90 per cent of stroke victims receive no treatment because of delays in diagnosis, resulting in thousands of preventable deaths and severe disabilities.
POCKiT diagnostics co-founder Edoardo Gaude said: “We believe our simple, portable and affordable device can save countless lives and improve the outcomes for even more stroke sufferers.”
There are more than 100,000 strokes in the UK every year.
POCKiT is appealing for public support in the competition, which includes a people’s vote for the winner. You can register your backing for POCKiT by logging on to the [email protected] website http://peopleschoice.pitchatpalace.com/entry/233/pockit-diagnostics
Edoardo said: “Public support would mean a great deal to us and help us so much in our mission to help people who suffer a stroke. It’s simply wrong that so many do not receive appropriate treatment.”
[email protected] was set up in 2014 to support the next generation of entrepreneurs. The winners will receive expert help from world leading business people, access to funding, networks and markets.
POCKiT Diagnostics’ chief executive Gonzalo Ladreda said: “It’s a unique opportunity to pitch in front of some of the most influential people in the world.”
Director of the Accelerate Cambridge programme at Cambridge Judge Business School, Hanadi Jabado, added: “POCKiT not only accelerates diagnosis and treatment, it also saves the lives of those misdiagnosed and undiagnosed.
“The team behind the device do not only have the passion but also the determination and the skills to bring this technology to patients all over the world who urgently need this device.”
[email protected] 10.0 is a highlight of the UK pitching calendar and follows regional heats including a Boot Camp at the Judge earlier this month.
• Pictured from left: CEO Gonzalo Ladreda, chief innovation officer Edoardo Gaude and chief scientific officer Marcos Ladreda